Log In
Print
BCIQ
Print
Print this Print this
 

doxepin (Silenor)

Also known as: SO-101

  Manage Alerts
Collapse Summary General Information
Company Pernix Therapeutics Holdings Inc.
DescriptionLow-dose tricyclic doxepin
Molecular Target Histamine H1 receptor (HRH1) ; Histamine receptor
Mechanism of ActionHistamine H1 receptor antagonist
Latest Stage of DevelopmentMarketed
IndicationInsomnia
Partner

CJ Group; Paladin Labs Inc.; Procter & Gamble Co.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today